Zimmer Biomet Holdings, Inc (NYSE:ZBH) reported fourth-quarter adjusted EPS of $2.31, up from $2.20 a year ago, beating the ...

With the $1.1 billion acquisition, Zimmer Biomet expects its sports medicine, extremities and trauma segment will outpace ...

CEO Ivan Tornos highlighted that Zimmer Biomet achieved nearly 5% constant currency sales growth in Q4 2024, marking the 12th consecutive quarter of mid-single-digit or better growth. The performance ...

Through the $1.1 billion acquisition, Zimmer Biomet expects its sports medicine, extremities and trauma segment to outpace hips and knees, moving forward, according to a Feb. 6 report from Medtech ...

Good morning, ladies and gentlemen, and welcome to the Zimmer Biomet Fourth Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, ...

Zimmer Biomet Holdings Inc (ZBH) reports robust Q4 performance with nearly 5% constant currency revenue growth and outlines ...

Medical device maker Zimmer Biomet Holdings forecast full-year adjusted profit below Wall Street estimates on Thursday, as it ...

Zimmer Biomet (NYSE: ZBH) shares dipped slightly today on fourth-quarter results that came in just ahead of the consensus ...

Fourth quarter net sales of $2.023 billion increased 4.3% and 4.9% on a constant currency1 basis Fourth quarter diluted earnings per share were $1.20; adjusted1 ...

Despite reporting better-than-expected Q4 2024 results, shares of Zimmer Biomet (NYSE:ZBH) fell in the morning hours Thursday after the orthopedic device maker set its 2025 outlook below consensus.

Zimmer Biomet Holdings, Inc. ZBH posted fourth-quarter 2024 adjusted earnings per share (EPS) of $2.31, beating the Zacks ...

In a report released today, Jason Wittes from Roth MKM maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report), with a price ...